Finasteride + Minoxidil + Tretinoin 0.25%/5%/0.03%
- A topical formulation combining finasteride, minoxidil, and tretinoin available through provider-guided care.
- Treatment requires review by a licensed healthcare provider and a prescription when clinically appropriate.
This topical formulation contains finasteride 0.25%, minoxidil 5%, and tretinoin 0.03%. Your healthcare provider determines whether this combination is appropriate based on your individual treatment needs and clinical circumstances. Tretinoin 0.025% has FDA-labeled use in certain topical acne products, but that does not establish FDA approval of this 0.03% combination formulation. There is currently no FDA-approved topical finasteride formulation.
Use this topical formulation exactly as prescribed by your healthcare provider. Follow the specific application instructions supplied with your prescription and do not change the amount or frequency without provider guidance.
Topical finasteride may be absorbed through the skin and can cause systemic or local adverse effects. FDA has reported adverse events associated with compounded topical finasteride, including local irritation and effects similar to those reported with oral finasteride. Tretinoin may also cause dryness, redness, peeling, irritation, and increased sensitivity to sunlight.
Your healthcare provider determines whether this formulation is appropriate after considering your health history, medications, skin and scalp concerns, and individual treatment needs.
Start Your Skin Treatment
Care Journey
A simple, provider-guided process to determine whether this topical formulation may be appropriate for your individual needs.
- 1Get Started
Provide the information needed for a licensed healthcare provider to understand your treatment needs and concerns.
Start online
- 2Provider Review
A licensed healthcare provider reviews your information and determines whether this treatment may be clinically appropriate for you.
Prescription required
- 3Start Your Treatment
If prescribed, receive your topical treatment and follow the application instructions provided by your healthcare provider.
Provider-guided care
Important Things to Know
Before Starting Treatment
Review important considerations about the ingredients, application, topical finasteride exposure, skin reactions, and provider-guided care.
- Understanding the Three Active Ingredients
- How to Apply Your Prescribed Treatment
- Topical Finasteride and Systemic Exposure
- Avoiding Unintended Medication Transfer
- Skin Irritation and Sun Sensitivity
- Monitoring Your Treatment Response
This formulation requires evaluation and a prescription from a licensed healthcare provider. Compounded topical finasteride products are not FDA-approved. FDA has identified potential risks associated with compounded topical finasteride and recommends discussing those risks with a healthcare provider before treatment.
Explore More
Treatment Options
Explore other skin-care treatment options available through provider-guided care and review which approach may be appropriate for your needs.
Hyaluronic Acid + Niacinamide + Tretinoin 0.5%/4%/0.025%
Starts atFrom $99/moPrescription requiredFinasteride + Minoxidil + Tretinoin 0.25%/5%/0.03% (you’re viewing this)
Starts atFrom $99/moPrescription required
Your Skin Care
Step by Step
Your provider determines the appropriate treatment approach and may review your response and tolerance over time.
If prescribed, your provider will explain how to apply the formulation and review important safety precautions.
Use the formulation according to your prescription and the application instructions provided by your healthcare provider.
Your provider may review your response, tolerance, and ongoing treatment needs to determine the appropriate next step.
Treatment plans, application instructions, and ongoing care vary by patient. Do not change your treatment without discussing it with your healthcare provider.
Frequently Asked Questions
It is a topical formulation containing finasteride 0.25%, minoxidil 5%, and tretinoin 0.03%. The formulation requires provider evaluation to determine whether it is appropriate for an individual patient's treatment needs.
No. FDA states that there is currently no FDA-approved topical formulation of finasteride. Compounded topical finasteride products do not have FDA-approved labeling.
FDA has received reports of adverse events associated with compounded topical finasteride, including local skin reactions and systemic effects similar to those associated with oral finasteride. Topical use can also create a risk of unintended exposure through transfer to another person.
Yes. Tretinoin can cause dryness, redness, peeling, and irritation and can increase sensitivity to sunlight. Follow your provider's instructions and contact your healthcare provider if significant irritation occurs.
Use the formulation exactly as prescribed and follow the application instructions supplied with your medication. Because this is a specific combination formulation, do not substitute instructions from another finasteride, minoxidil, or tretinoin product.
This product requires evaluation and a prescription from a licensed healthcare provider. The exact formulation, treatment suitability, application instructions, and ongoing care should be discussed with your provider and reviewed against the dispensing pharmacy's product information.